BACKGROUND: Combined androgen blockade for the treatment of metastatic prostate cancer consists of an antiandrogen drug plus castration. In a previous trial, we found that adding the antiandrogen flutamide to leuprolide acetate (a synthetic gonadotropin-releasing hormone that results in medical abla...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!